The long ternn goal of this grant proposal is to provide evidence that a low molecular weight G-protein, RhoA, serves a nodal role in protecting cardiomyocytes from stress. Stimuli that activate cardiac RhoA include sphingosine-1-phosphate (SIP) and other ligands for a subset of G-protein coupled receptors (GPCRs) that couple to the G12/13 family of G-proteins. These ligands are generated in response to ischemic stress and inflammation and can stimulate multiple pleiotropic effects of RhoA which protect the heart from damage. Using mouse models with gain and loss of function for RhoA we identified a mechanism for acute protection against ischemia reperfusion injury involving phosphorylation of protein kinase D and a cytoskeletal protein, cofilin2, that translocates to mitochondria. RhoA signaling also leads to transcriptional gene regulation, providing an additional mechanism for protection against more chronic cardiac stress. We have also observed direct effects of RhoA on mitochondrial morphology and autophagy.
Three specific aims elucidate these pathways and their physiological roles.
Aim #1 examines the effects of cardiac RhoA expression or deletion in a more chronic ischemic model, myocardial infarction (Ml); identifies the SIP3 receptor subtype as the mediator of RhoA signaling and protection using SIP3 receptor KO mice and subtype selective drugs; determines whether ischemic injury is accentuated in mice deleted for G12/13 ;and identifies other cardiomyocyte GPCRs that activate RhoA.
Aim #2 examines activation of transcription factors regulated downstream of RhoA (MRTF-A, YAP, NFkB) in WT vs RhoA. TG and KO mice exposed to chronic stress (TAC, Ml); the role of the matricellular integrin binding protein CCN1, an MRTF-A and YAP regulated gene, in hypertrophy decompensation and Ml injury using cardiac specific CCN1 KO mice; other genes will also be identified as potential mediators of salutary or deleterious effects of RhoA activation.
Aim #3 will examine the relationship between RhoA mediated regulation of cofilin2 and its effects on mitochondrial function, Bax translocation and cell death. Other studies will examine effects of RhoA localized to mitochondria on the stability of PINK, ubiquitation of mitochondrial proteins and development of mitophagy, another pathway for cardiomyocyte protection. The biomedical significance of this work is in elucidating pathways elicited by myriad GPCR agonists or interventions that activate RhoA in the heart. Understanding which receptors activate these pathways and their downstream molecular mechanisms would provide the basis for therapeutic interventions to selectively enhance salutary vs. deleterious effects of RhoA.

Public Health Relevance

Heart attacks (myocardial infarcts) results from loss of oxygen to the heart (ischemia) and even when treated by restoration of blood flow (reperfusion) progress to development of heart failure and premature death. We examine novel pathways which could provide therapies to increase the survival of heart cells and thereby limit morbidity due to loss of heart function

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL028143-32
Application #
8982037
Study Section
Special Emphasis Panel (NSS)
Program Officer
Schwartz, Lisa
Project Start
1982-08-01
Project End
2020-01-31
Budget Start
2016-02-01
Budget End
2017-01-31
Support Year
32
Fiscal Year
2016
Total Cost
$421,988
Indirect Cost
$149,738
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Suetomi, Takeshi; Willeford, Andrew; Brand, Cameron S et al. (2018) Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II ? Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation 138:2530-2544
Willeford, Andrew; Suetomi, Takeshi; Nickle, Audrey et al. (2018) CaMKII?-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis. JCI Insight 3:
Yu, Olivia M; Benitez, Jorge A; Plouffe, Steven W et al. (2018) YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity. Oncogene 37:5492-5507
Brand, Cameron S; Tan, Valerie P; Brown, Joan Heller et al. (2018) RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes. Cell Signal 50:48-57
Dusaban, Stephanie S; Chun, Jerold; Rosen, Hugh et al. (2017) Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J Neuroinflammation 14:111
Yung, Bryan S; Brand, Cameron S; Xiang, Sunny Y et al. (2017) Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection. J Mol Cell Cardiol 103:1-10
Sanna, M Germana; Vincent, Kevin P; Repetto, Emanuela et al. (2016) Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction. Mol Pharmacol 89:176-86
Yu, Olivia M; Miyamoto, Shigeki; Brown, Joan Heller (2016) Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation. Mol Cell Biol 36:39-49
Castaldi, Alessandra; Chesini, Gino P; Taylor, Amy E et al. (2016) Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs. Cell Signal 28:871-9
Miyamoto, Shigeki; Brown, Joan Heller (2016) Drp1 and Mitochondrial Autophagy Lend a Helping Hand in Adaptation to Pressure Overload. Circulation 133:1225-7

Showing the most recent 10 out of 34 publications